The evaluation of complaint data for the product and likely cause architect hbsag qualitative confirmatory lot 04330fn00 identified normal complaint activity and there are no trends for the product related to patient results.No customer returns were available for evaluation.Additionally, clinical testing of the architect hbsag qualitative confirmatory assay has been evaluated with a retained in-house kit of the same lot# 04330fn00 and met all specifications, confirming that this lot is meeting the product requirements.A review of the manufacturing documentation did not identify any issues associated with the customers observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the architect hbsag qualitative confirmatory (lot# 04330fn00).
|